Supplementum 20 Ad Cardiovascular Medicine 2011;14(5) 25 May 2011

Supplementum 20 Ad Cardiovascular Medicine 2011;14(5) 25 May 2011

Cardiovascular Medicine Kardiovaskuläre Medizin / Médecine cardiovasculaire supplementum 20 ad cardiovascular Medicine 2011;14(5) 25 May 2011 www.cardiovascmed.ch Jahrestagung der schweizerischen gesellschaft für Kardiologie (sgK) gastgesellschaften: schweizerische gesellschaft für sportmedizin (sgsm) schweizerische gesellschaft für pädiatrische Kardiologie (sgpK) schweizerische gesellschaft für herz- und thorakale gefässchirurgie (sghc) schweizerische hypertonie gesellschaft (shg) swiss cardiovascular therapists (sct) schweizerischer verein für pflegewissenschaften (vfp) assemblée annuelle de la société suisse de cardiologie (ssc) sociétés invitées: société suisse de médecine du sport (ssms) société suisse de cardiologie pédiatrique (sscp) société suisse de chirurgie cardiaque et vasculaire thoracique (sscc) société suisse d’hypertension (ssh) swiss cardiovascular therapists (sct) association pour les sciences infirmières (apsi) Basel, 8.–10. Juni 2011 official journal of the swiss society of cardiology, the swiss society of hypertension, the swiss society of angiology and the swiss society of paediatric cardiology impressum Cardiovascular Medicine www.cardiovascmed.ch Official journal of the Swiss Society of Cardiology, the Swiss Society of Hypertension, the Swiss Society of Angiology and the Swiss Society of Paediatric Cardiology Kardiovaskuläre Medizin / Médecine cardiovasculaire VET EL IC H A S C A A R T D E I I O C L O S O G A I C editors Editors in chief Section editors: Section editors: Section editors: Editors Thomas F. Lüscher, Zürich Images in cardiovascular The new compound The interesting ECG Paul Erne, Luzern René Lerch, Genève medicine Jérôme Biollaz, Lausanne Michael Kühne, Basel Augusto F. Gallino, Bellinzona Alain Delabays, Morges Georg Noll, Zürich Jürg Schläpfer, Lausanne Lukas Kappenberger, Lausanne Deputy editors Michel Zuber, Luzern Bernhard Meier, Bern Georg Noll Section editor: Section editors: Matthias Pfisterer, Basel Jan Steffel The new device Evidence-based Hans Rickli, St. Gallen Haran Burri, Genève cardiology Christian Seiler, Bern Stephan Windecker, Bern Heiner Bucher, Basel Bernard Waeber, Lausanne Jens Hellermann, Altstätten Jörg Muntwyler, Kloten editorial Board D. Atar, Oslo F. Cosentino, Rom D. Keller Lang, Zürich J. Philippe, Genève U. Sigwart, Genève E. Battegay, Zürich H. Darioli, Lausanne P. Kaufmann, Zürich O. Ratib, Genève L. Spieker, Grenchen O. Bertel, Zürich J. Deanfield, London B. Kwak-Chanson, Genève T. J. Resink, Basel P. Suter, Zürich M. G. Bianchetti, Bellinzona F. Eberli, Zürich M. Lachat, Zürich P. Rickenbacher, Bruderholz S. Ulrich, Zürich P. Bösiger, Zürich E. Eckhout, Lausanne R. Lehmann, Zürich W. Riesen, St. Gallen E. Valsangiacomo, Zürich F. R. Bühler, Basel U. Eriksson, Wetzikon F. Mach, Genève M. Roffi, Genève P. M. Vanhoutte, Hongkong M. Burnier, Lausanne D. Gämperli, Zürich M. Maeder, St. Gallen F. Ruschitzka, Zürich G. Vassalli, Lausanne P. Buser, Basel W. Häfeli, Heidelberg W. Maier, Zürich H. Saner, Olten/Bern G. K. von Schulthess, Zürich P. G. Camici, London D. Hayoz, Lausanne C. Marone, Bellinzona U. Scherrer, Lausanne L. von Segesser, Lausanne T. Carrel, Bern K. Jäger, Basel F. H. Messerli, New York, USA J. Schwitter, Zürich D. Shah, Genève R. Corti, Zürich A. Jaussi, Yverdon-les-Bains T. C. Moccetti, Lugano G. Zünd, Zürich R. Jenni, Zürich P. Mohacsi, Bern J. J. P. Kastelein, Amsterdam S. Osswald, Basel Z. S. Katusic, Rochester, USA G. Pedrazzini, Lugano impressum Contact Publishing company Advertising Retail price: Fr. 125.–; authorisation of EMH on the basis Cardiovascular Medicine EMH EMH Swiss Medical Single issue: Fr. 20.–. of a written agreement. EMH Swiss Medical Publishers Ltd. Publishers Ltd. Issues per year: 11 Creative Commons summary: Swiss Medical Publishers Ltd. Steinentorstrasse 13 Ariane Furrer ISSN 1664-2031 http://creativecommons.org/ Farnsburgerstrasse 8 CH-4010 Basel Assistant Advertising Department licenses/by-nc-nd/2.5/ch;fulllicence: CH-4132 Muttenz Phone +41 (0)61 467 85 55 Farnsburgerstrasse 8 © EMH Swiss Medical Publishers http://creative commons.org/licen Phone +41 (0)61 467 85 58 Fax +41 (0)61 467 85 56 CH-4132 Muttenz 1 Ltd. (EMH), 2011.«Cardiovascular ses/by-nc-nd/2.5/ch/legalcode.de Fax +41 (0)61 467 85 56 www.emh.ch Phone +41 (0)61 467 85 88 Medicine» is an open access pub- [email protected] Fax +41 (0)61 467 85 56 lication of EMH. Accordingly, EMH www.cardiovascmed.ch Publishing director EMH [email protected] grants to all users on the basis Natalie Marty of the Creative Commons license Managing editor ([email protected]) Printing and reprints «Attribution – Non commercial – Nadine Leyser Schwabe AG No Derivative Works» for an un- Marketing EMH ([email protected]) Farnsburgerstrasse 8 limited period the right to copy, Thomas Gierl Postfach 832 distribute, display, and perform the Editorial office Head, Marketing CH-4132 Muttenz 1 work as well as to make it publicly Gisela Wagner and Communication Phone +41 (0)61 467 85 85 available on condition that (1) the ([email protected]) Farnsburgerstrasse 8 Fax +41 (0)61 467 85 86 work is clearly attributed to the CH-4132 Muttenz 1 [email protected] author or licensor (2) the work is Language editors Phone +41 (0)61 467 85 49 www.schwabe.ch not used for commercial purposes Susanne Redle (deutsch) Fax +41 (0)61 467 85 56 and (3) the work is not altered, Kirsten Clift, Roy Turnill [email protected] (english) transformed, or built upon. Any use of the work for commercial purposes needs the explicit prior Partner Die Redaktion der «Cardiovascular Medicine» und der Schweizerische Ärzteverlag EMH danken der Firma MSD, die mit Ihrem Engagement die Herstellung dieser Zeitschrift ohne jegliche redaktionelle Einflussnahme unterstützt: DEM PATIENTEN VERPFLICHTET. In unserer Verpflichtung dem Patienten gegenüber ermöglichen wir weltweit die Versorgung mit dringend benötigten Medikamenten und unterstützen nachhaltige Gesundheitsprogramme vor Ort. Editores Medicorum Helveticorum inhalt / sommaire vorträge / présentations orales Freie Mitteilungen 1 / communications libres 1 Mitral and aortic valve repair 4 S Freie Mitteilungen 2 / communications libres 2 Basic research 6 S Freie Mitteilungen 3 / communications libres 3 Stent 8 S Freie Mitteilungen 4 / communications libres 4 Risk factors 10 S Freie Mitteilungen 5 / communications libres 5 Heart failure: new insights 12 S Freie Mitteilungen 6 / communications libres 6 Acute coronary syndrome 15 S Freie Mitteilungen 7 / communications libres 7 Imaging: technology, prognostics and “unusual exertion heart diseases” 17 S Freie Mitteilungen 8 / communications libres 8 Clinical cases 20 S Freie Mitteilungen 9 / communications libres 9 Pacing and ICD 23 S Freie Mitteilungen 10 / communications libres 10 Basic research 26 S Freie Mitteilungen 11 / communications libres 11 Coronary heart disease and auricular occlusion 28 S Freie Mitteilungen 12 / communications libres 12 Clinical cases 30 S Freie Mitteilungen 13 / communications libres 13 Aortic revalving and aortic dissection 33 S Freie Mitteilungen 14 / communications libres 14 Imaging 35 S Freie Mitteilungen 15 / communications libres 15 Arrhythmias and ablation 37 S Cardiovascular Medicine 2011;14(5): Suppl 20 2 S inhalt / sommaire poster / posters Moderierte poster / posters modérés P190–P207 39 S postergruppe 1 / groupe de posters 1 Pathophysiology / Molecular biology 46 S postergruppe 2 / groupe de posters 2 Rhythmology and pacemakers 51 S postergruppe 3 / groupe de posters 3 Congestive heart failure, valvular heart disease 57 S postergruppe 4 / groupe de posters 4 Coronary artery disease, PCI 64 S postergruppe 5 / groupe de posters 5 Risk factors, hypertension, epidemiology, rehabilitation, thromboembolism 72 S postergruppe 6 / groupe de posters 6 Cardiac imaging 77 S postergruppe 7 / groupe de posters 7 Clinical cardiology 86 S postergruppe 8 / groupe de posters 8 Cardiac surgery 92 S erstautorenverzeichnis / liste des premiers auteurs 100 S Cardiovascular Medicine 2011;14(5): Suppl 20 3 S Freie mitteilungen 1 – communications libres 1 Mitral and aortic valve repair 28 29 Acute haemodynamic changes after percutaneous Correction of mitral regurgitation by MitraClip in non- mitral valve repair responders to cardiac resynchronization therapy improves symptoms and promotes reverse remodeling O. Gaemperli, D. Sürder, P. Biaggi, D. Hürlimann, I. Buehler, D. Bettex, C. Felix, J. Grünenfelder, R. Corti (Zürich, Lugano, CH) A. Auricchio, W. Schillinger, S. Meyer, F. Maisano, R. Hoffmann, Aims: Percutaneous mitral valve repair (MVR) using the Evalve G. Ussia, G.B. Pedrazzini, J. van der Heyden, S. Fratini, C. Klersy, MitraClip device has recently been developed. This method O. Franzen for the PERMIT-CARE delivers a clip via atrial trans-septal puncture grasping the mitral Introduction: Moderate to severe functional mitral regurgitation leaflets and thereby creating a double orifice valve. The aim of the (MR) may persist after cardiac resynchronization therapy (CRT), present study was to assess immediate hemodynamic changes contributing to less/no response to CRT. Percutaneous repair with after MVR with the MitraClip device using right heart the MitraClip (MC; Abbott Vascular, Menlo Park, CA) has be catheterization. proposed as an additional therapeutic option in select patients Methods: Patients with moderate to severe (3+) and severe (4+) (pts) with significant MR (>2+). The Percutaneous Mitral Valve mitral regurgitation (MR) due to functional (62%), degenerative Repair in Cardiac resynchronization Therapy (PERMIT- CARE)

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    101 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us